{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:43:22Z","timestamp":1791441802497,"version":"4.3.3"},"reference-count":48,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>As the number of patients diagnosed with endometrial cancer rises, so does the number of patients who undergo surgical treatment, consisting of radical hysterectomy, bilateral salpingo-oophorectomy, and bilateral pelvic lymphadenectomy or lymph node sampling. The latter entail intra- and post-surgical complications, such as lymphedema and increased intra-operative bleeding, which often outweigh their benefits. Sentinel Lymph Node (SLN) sampling is now common practice in surgical management of breast cancer, as it provides important information about the disease without jeopardizing surgical radicality and patient outcomes. While this technique has also been shown to be feasible in patients with endometrial cancer, there is little consensus on several aspects, such as tracer injection volume and site, pathological ultrastaging, and result interpretation. The aim of this review is to analyze the current literature on SLN assessment in order to help standardize the procedure.<\/jats:p>","DOI":"10.3390\/cancers16183202","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T07:38:57Z","timestamp":1726817937000},"page":"3202","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Sentinel Lymph Node Assessment in Endometrial Cancer: A Review"],"prefix":"10.3390","volume":"16","author":[{"given":"Christopher","family":"Clark","sequence":"first","affiliation":[{"name":"Azienda Ospedaliera Universitaria \u201cPoliclinico di Bari\u201d-Clinica di Ginecologia e Ostetricia, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-6421","authenticated-orcid":false,"given":"Vera","family":"Loizzi","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera Universitaria \u201cPoliclinico di Bari\u201d-Clinica di Ginecologia e Ostetricia, 70124 Bari, Italy"},{"name":"Gynecologic Oncology Unit, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5745-372X","authenticated-orcid":false,"given":"Gennaro","family":"Cormio","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera Universitaria \u201cPoliclinico di Bari\u201d-Clinica di Ginecologia e Ostetricia, 70124 Bari, Italy"},{"name":"Gynecologic Oncology Unit, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Lopez","sequence":"additional","affiliation":[{"name":"Gynecologic Oncology Unit, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"ref_1","unstructured":"American Cancer Society (2024, August 01). Cancer Facts & Figures 2024 [Internet]. American Cancer Society: Atlanta. Available online: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2024\/2024-cancer-facts-and-figures-acs.pdf."},{"key":"ref_2","first-page":"28","article-title":"Comprehensive surgical staging for endometrial cancer","volume":"5","author":"Rungruang","year":"2012","journal-title":"Rev. Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/1097-0142(196001\/02)13:1<77::AID-CNCR2820130114>3.0.CO;2-D","article-title":"Observations on a \u201csentinel node\u201d in cancer of the parotid","volume":"13","author":"Gould","year":"1960","journal-title":"Cancer"},{"key":"ref_4","first-page":"207","article-title":"Sentinel lymph node mapping in endometrial cancer to reduce surgical morbidity: Always, sometimes, or never","volume":"21","author":"Daniilidis","year":"2022","journal-title":"Prz Menopauzalny"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00404-011-1884-z","article-title":"Detection and credibility of sentinel node in vulvar cancer: A single institutional study and short review of literature","volume":"284","author":"Akrivos","year":"2011","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): A multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"46601","DOI":"10.18632\/oncotarget.16662","article-title":"Sentinel lymph node mapping in endometrial cancer: A systematic review and meta-analysis","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/IGC.0000000000000158","article-title":"ATL: A Prospective Study","volume":"24","author":"Parra","year":"2014","journal-title":"Inl. J. Gynecol. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1470-2045(11)70070-5","article-title":"Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: A prospective multicentre study (SENTI-ENDO)","volume":"12","author":"Ballester","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S1470-2045(18)30448-0","article-title":"Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): A randomised, phase 3, multicentre, non-inferiority trial","volume":"19","author":"Frumovitz","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2012.10.008","article-title":"Transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR): A new method for sentinel lymph node detection in endometrial cancer","volume":"128","author":"Pahisa","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00404-017-4468-8","article-title":"Subserosal uterine injection of blue dye for the identification of the sentinel node in patients with endometrial cancer: A feasibility study","volume":"296","author":"Biliatis","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2020.08.030","article-title":"Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group","volume":"140","author":"Ditto","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1245\/s10434-007-9516-3","article-title":"Status of sentinel lymph node biopsy in gynecological cancers","volume":"15","author":"Levenback","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.7150\/jca.78009","article-title":"Patterns of lymph node metastases and their implications in individualized radiotherapeutic clinical target volume delineation of regional lymph nodes in patients with endometrial cancer","volume":"13","author":"Teng","year":"2022","journal-title":"J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2013.10.002","article-title":"Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer","volume":"132","author":"Kumar","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00404-019-05137-5","article-title":"Risk factors for failure of sentinel lymph node mapping using indocyanine green\/near-infrared fluorescent imaging in endometrial cancer","volume":"299","author":"Kankaya","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2019.08.008","article-title":"Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: Predictors of unsuccessful mapping","volume":"155","author":"Tortorella","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_19","first-page":"824","article-title":"Assessment of sentinel Lymph node mapping with different volumes of Indocyanine green in early-stage ENdometrial cancer: The ALIEN study","volume":"34","author":"Mauro","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2018.06.001","article-title":"Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer","volume":"150","author":"Body","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1136\/ijgc-2020-001724","article-title":"Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: The SENTIFAIL study\u2014A multicentric analysis of predictors of failed mapping","volume":"30","author":"Sozzi","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhang-Yin, J., Mauel, E., and Talpe, S. (2024). Update on Sentinel Lymph Node Methods and Pathology in Breast Cancer. Diagnostics, 14.","DOI":"10.3390\/diagnostics14030252"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/ijgc-2023-005157","article-title":"Establishing guidelines for sentinel lymph node ultrastaging in endometrial cancer","volume":"34","author":"Chiang","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): Patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","volume":"20","author":"Powell","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ygyno.2019.07.018","article-title":"Lymph node micrometastases and outcome of endometrial cancer","volume":"154","author":"Ignatov","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ygyno.2021.02.017","article-title":"Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I\/II endometrioid endometrial cancer: To treat or not to treat?","volume":"161","author":"Backes","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jmig.2016.03.017","article-title":"Sampling in Atypical Endometrial Hyperplasia: Which Method Results in the Lowest Underestimation of Endometrial Cancer? A Systematic Review and Meta-analysis","volume":"23","author":"Bourdel","year":"2016","journal-title":"J. Minim Invasive Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S1701-2163(16)32969-3","article-title":"Significance of concurrent endometrial cancer in women with a preoperative diagnosis of atypical endometrial hyperplasia","volume":"30","author":"Giede","year":"2008","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/ijgc-2023-005202","article-title":"Concurrent endometrial cancer in atypical endometrial hyperplasia and the role of sentinel lymph nodes: Clinical insights from a multicenter experience","volume":"34","author":"Rosati","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ygyno.2020.03.025","article-title":"Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma","volume":"157","author":"Mueller","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/ijgc-2023-005173","article-title":"Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: A multicenter observational study","volume":"34","author":"Fumagalli","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jogc.2021.04.014","article-title":"Sentinel Lymph Node Sampling as an Alternative to Lymphadenectomy in Patients With Endometrial Cancer and Obesity","volume":"43","author":"Matanes","year":"2021","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2014.03.019","article-title":"Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: Results of a retrospective multicenter study","volume":"133","author":"Raimond","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/ijgc-2021-003029","article-title":"A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer\u2014ENDO-3: ANZGOG trial 1911\/2020","volume":"31","author":"Obermair","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1136\/ijgc-2020-001698","article-title":"A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial)","volume":"30","author":"Grassi","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ijgo.14307","article-title":"Sentinel lymph node mapping in endometrial cancer: A comparison of main national and international guidelines","volume":"160","author":"Dick","year":"2023","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Yashar","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2017.05.027","article-title":"Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations","volume":"146","author":"Holloway","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jamasurg.2020.5060","article-title":"Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging","volume":"156","author":"Cusimano","year":"2021","journal-title":"JAMA Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12282-011-0327-9","article-title":"Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer","volume":"20","author":"Shiozawa","year":"2013","journal-title":"Breast Cancer"},{"key":"ref_44","unstructured":"Thompson, W., and Arg\u00e1ez, C. (2024, August 01). Magnetic Localization System for Sentinel Lymph Node Biopsy: A Review of the Diagnostic Accuracy, Cost-Effectiveness, and Guidelines [Internet]. Canadian Agency for Drugs and Technologies in Health: Ottawa, ON, Canada, 26 February 2020, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562944\/."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Murakami, K., Kotani, Y., Suzuki, A., Takaya, H., Nakai, H., Matsuki, M., Sato, T., Mandai, M., and Matsumura, N. (2020). Superparamagnetic iron oxide as a tracer for sentinel lymph node detection in uterine cancer: A pilot study. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-64926-0"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ejso.2023.02.006","article-title":"Hysterectomy alone vs. hysterectomy plus sentinel node mapping in endometrial cancer: Perioperative and long-term results from a propensity-score based study","volume":"49","author":"Bogani","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_47","first-page":"A103","article-title":"2022-RA-659-ESGO\u2005The role of molecular classification in endometrial cancers with lymph nodes metastasis","volume":"32","author":"Schivardi","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Liu, X.F., Yan, B.C., Li, Y., Ma, F.H., and Qiang, J.W. (2022). Radiomics Nomogram in Assisting Lymphadenectomy Decisions by Predicting Lymph Node Metastasis in Early-Stage Endometrial Cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.894918"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/18\/3202\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:00:40Z","timestamp":1760112040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/18\/3202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":48,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["cancers16183202"],"URL":"https:\/\/doi.org\/10.3390\/cancers16183202","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]}}}